Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 218,999 | 250,026 | 242,712 | 227,807 | 230,269 |
| Cost of Goods | 27,933 | 28,457 | 29,139 | 26,343 | 40,056 |
| Gross Profit | 191,066 | 221,569 | 213,573 | 201,464 | 190,213 |
| Operating Expenses | 104,094 | 101,556 | 104,510 | 104,616 | 94,329 |
| Operating Income | 87,905 | 120,470 | 109,202 | 97,191 | 95,940 |
| Interest Expense | -690 | 85 | 283 | 114 | 392 |
| Other Income | 1,856 | 2,109 | 2,147 | 1,545 | 2,534 |
| Pre-tax Income | 90,451 | 122,494 | 111,066 | 98,622 | 98,082 |
| Income Tax | 28,404 | 40,012 | 24,301 | 35,295 | 34,394 |
| Net Income Continuous | 62,047 | 82,482 | 86,765 | 63,327 | 63,688 |
| Minority Interests | 299 | 421 | 378 | -1,684 | 236 |
| Net Income | $61,748 | $82,061 | $86,387 | $65,011 | $63,452 |
| EPS Basic Total Ops | 0.55 | 0.73 | 0.77 | 0.58 | 0.56 |
| EPS Basic Continuous Ops | 0.56 | 0.74 | 0.77 | 0.56 | 0.56 |
| EPS Diluted Total Ops | 0.55 | 0.72 | 0.76 | 0.58 | 0.55 |
| EPS Diluted Continuous Ops | 0.55 | 0.73 | 0.76 | 0.56 | 0.55 |
| EBITDA(a) | $105,405 | $136,546 | $121,976 | $109,317 | $106,497 |